Tam Phan, PharmD
The findings of studies assessing drug interactions in transgender men and women taking hormone therapy and HIV pre-exposure prophylaxis may help assuage concerns that prevent PrEP use.
A recent systematic review examining facilitators of and barriers to PrEP use in trans people found that despite relatively high awareness of PrEP, uptake was low, partly because of beliefs that there were interactions between the prophylactic regimen and hormone therapy (